DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Walter HS, Rule SA, Dyer MJ. , et al.
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
Blood 2016;
127 (04) 411-419
We do not assume any responsibility for the contents of the web pages of other providers.